The profile you requested (/company/jbs) does not exist or is not published.
You are viewing a limited version of this profile. To access i3's full capabilities.
REG Life Sciences
Save
Company logo (jpg or png)
Parent company

Short description

Developer of genetically modified microbes, converting feedstock into renewable fuels and chemicals in a one-stage fermentation process

Founded in 2005
Founded in

Company type Acquired Public ()
Company type

Industry Group materials & chemicals

Sector fuels & chemicals

TRL Range 7-8
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters South San Francisco, CA South San Francisco, United States
Address
City
State
Zip
Country

Parent Companies

Updated by Cleantech Group on 09/15/2021

Traction
  • 1 M&A items
Similar companies
Customers
Save
Date Company
Partnerships
Save
Date Partner Type
07/18/2011
Virdia Virdia
LS9 in conjunction with HCL CleanTech was awarded $9 million DOE grant for process improvement and demonstration at scale.
View source    
Confirmed by Virdia
Technology Partner
Investment Rounds
Save

IPO INFORMATION

Date

IPO status

IPO Type

Amount

Initial shares

Ticker symbol

Exchange listed

Prospectus URL

Prospectus

Source URL

Source

Description

Date Investors Type Amount
05/14/2012 Florida Opportunity Fund Florida Opportunity Fund (1)
Post-money valuation of
LS9 received $4.5 million from the Florida Opportunity Fund's Clean Energy Investment Program to help fund the retrofit of LS9's demonstration facility in Okeechobee, Florida.
Growth Equity $4,500,000
Click to add IPO information
Products
Save
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font